Search

Your search keyword '"Deron Zbigniew"' showing total 8 results
Start Over Author "Deron Zbigniew"
8 results on '"Deron Zbigniew"'

1. Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

Author

Zarębska-Michaluk, Dorota, Piekarska, Anna, Jaroszewicz, Jerzy, Klapaczyński, Jakub, Mazur, Włodzimierz, Krygier, Rafał, Belica-Wdowik, Teresa, Baka-Ćwierz, Barbara, Janczewska, Ewa, Pabjan, Paweł, Dobracka, Beata, Lorenc, Beata, Tudrujek-Zdunek, Magdalena, Tomasiewicz, Krzysztof, Sitko, Marek, Garlicki, Aleksander, Czauż-Andrzejuk, Agnieszka, Citko, Jolanta, Dybowska, Dorota, Halota, Waldemar, Pawłowska, Małgorzata, Laurans, Łukasz, Deroń, Zbigniew, Buczyńska, Iwona, Simon, Krzysztof, Białkowska, Jolanta, Tronina, Olga, and Flisiak, Robert

Published
2020
Full Text
View/download PDF

2. THU-196-Efficacy of 8 versus 12-weeks treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-weeks regimen in real world setting

Author

Ewa Janczewska, Agnieszka Czauż-Andrzejuk, Robert Flisiak, Włodzimierz Mazur, Waldemar Halota, Horban Andrzej, Beata Dobracka, Marta Wawrzynowicz-Syczewska, Łukasz Laurans, Łukasz Socha, Tronina Olga, Iwona Orłowska, Simon Krzysztof, Rafał Krygier, Paweł Pabjan, Krzysztof Tomasiewicz, Teresa Belica-Wdowik, Klapaczynski Jakub, Małgorzata Pawłowska, Marek Sitko, Hanna Berak, Barbara Baka-Ćwierz, Jolanta Citko, Dorota Dybowska, Magdalena Tudrujek, Anna Piekarska, Jerzy Jaroszewicz, Dorota Zarebska-Michaluka, Beata Lorenc, Aleksander Garlicki, and Deron Zbigniew

Subjects
medicine.medical_specialty, Regimen, Hepatology, Chronic hepatitis, business.industry, Internal medicine, Medicine, LEDIPASVIR/SOFOSBUVIR, business
Published
2019
Full Text
View/download PDF

3. THU-140-Characteristics of patients and effectiveness of chronic hepatitis C treatment during the initial 4 years of access to interferon-free therapy

Author

Jolanta Citko, Teresa Belica-Wdowik, Agnieszka Czauż-Andrzejuk, Włodzimierz Mazur, Jolanta Białkowska-Warzecha, Piekarska Anna, Dobracka Beata, Łukasz Socha, Dorota Zarębska-Michaluk, Marek Sitko, Hanna Berak, Matgorzata Pawłowska, Krzysztof Tomasiewicz, Deron Zbigniew, Beata Lorenc, Robert Flisiak, Waldemar Halota, Simon Krzysztof, Iwona Orłowska, Magdalena Tudrujek, Dorota Dybowska, Tronina Olga, Rafał Krygier, Jerzy Jaroszewicz, Ewa Janczewska, Łukasz Laurans, and Klapaczynski Jakub

Subjects
medicine.medical_specialty, Hepatology, Chronic hepatitis, business.industry, Internal medicine, Interferon free, medicine, business, Gastroenterology
Published
2019
Full Text
View/download PDF

4. Real world experience with twelve weeks of therapy without ribavirin in genotype 1 HCV infected compensated cirrhotics

Author

Dorota Zarębska-Michaluk, Andrzej Gietka, Łukasz Socha, Marta Wawrzynowicz-Syczewska, I. Ortowska, Ewa Janczewska, Łukasz Laurans, A. Staniaszek, Magdalena Tudrujek, Aleksander Garlicki, Krzysztof Tomasiewicz, M. Pawtowska, Beata Lorenc, Jerzy Jaroszewicz, Marek Sitko, Jolanta Białkowska-Warzecha, Barbara Baka-Ćwierz, Anna Piekarska, H. Andrzej, Deron Zbigniew, Robert Flisiak, Jolanta Citko, Agnieszka Czauż-Andrzejuk, Rafał Krygier, Beata Dobracka, M. Wtodzimierz, Dorota Dybowska, Simon Krzysztof, Teresa Belica-Wdowik, Hanna Berak, and Waldemar Halota

Subjects
medicine.medical_specialty, chemistry.chemical_compound, Hepatology, chemistry, business.industry, Internal medicine, Ribavirin, Genotype, medicine, business, Gastroenterology
Published
2018
Full Text
View/download PDF

5. Sofosbuvir-based treatment of viral hepatitis C genotype 3 infection – A Polish real-world study

Author

Andrzej Gietka, Dorota Dybowska, Jolanta Białkowska-Warzecha, A. Staniaszek, Robert Flisiak, M. Pawtowska, Łukasz Socha, Anna Piekarska, Marta Wawrzynowicz-Syczewska, H. Andrzej, Agnieszka Czauż-Andrzejuk, Dorota Zarębska-Michaluk, Magdalena Tudrujek, Krzysztof Tomasiewicz, Marek Sitko, Barbara Baka-Ćwierz, Łukasz Laurans, Hanna Berak, Teresa Belica-Wdowik, I. Ortowska, Beata Lorenc, Simon Krzysztof, Beata Dobracka, M. Wtodzimierz, Waldemar Halota, Ewa Janczewska, Deron Zbigniew, Jerzy Jaroszewicz, Tronina Olga, and Aleksander Garlicki

Subjects
Hepatology, Sofosbuvir, business.industry, Genotype, medicine, Viral hepatitis, medicine.disease, business, Virology, medicine.drug
Published
2018
Full Text
View/download PDF

6. THU-217-Low risk of HBV reactivation in a large European cohort of HBV/ HCV coinfected patients treated with DAA

Author

Małgorzata Pawłowska, Rafał Krygier, Magdalena Tudrujek, Anna Piekarska, Iwona Buczyńska, Hanna Berak, Beata Dobracka, Dorota Dybowska, Krzysztof Tomasiewicz, Jerzy Jaroszewicz, Dorota Zarębska-Michaluk, Tronina Olga, Simon Krzysztof, Jolanta Białkowska-Warzecha, Waldemar Halota, Łukasz Socha, Aleksander Garlicki, Teresa Belica-Wdowik, Beata Lorenc, Deron Zbigniew, Klapaczynski Jakub, Jolanta Citko, Agnieszka Czauż-Andrzejuk, Włodzimierz Mazur, Ewa Janczewska, Robert Flisiak, and Maciej Piasecki

Subjects
Hepatology, business.industry, Cohort, Hbv reactivation, Medicine, business, Virology
Published
2019
Full Text
View/download PDF

7. THU-197-Comparative effectiveness of 8 versus 12 weeks of ombitasvir/paritaprevir/ritonavir and dasabuvir in treatment-naive patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

Author

Dorota Dybowska, Beata Dobracka, Jolanta Białkowska-Warzecha, Iwona Orłowska, Waldemar Halota, Agnieszka Czauż-Andrzejuk, Dorota Zarębska-Michaluk, Jolanta Citko, Włodzimierz Mazur, Aleksander Garlicki, Paweł Pabjan, Krzysztof Tomasiewicz, Marek Sitko, Barbara Baka-Ćwierz, Tronina Olga, Małgorzata Pawłowska, Teresa Belica-Wdowik, Robert Flisiak, Ewa Janczewska, Simon Krzysztof, Deron Zbigniew, Beata Lorenc, Magdalena Tudrujek, Klapaczynski Jakub, Rafał Krygier, Jerzy Jaroszewicz, and Łukasz Laurans

Subjects
medicine.medical_specialty, Dasabuvir, Hepatology, business.industry, Gastroenterology, Therapy naive, chemistry.chemical_compound, chemistry, Genotype 1b, Ombitasvir/paritaprevir/ritonavir, Internal medicine, medicine, Hepatic fibrosis, business
Published
2019
Full Text
View/download PDF

8. The efficacy of paritaprevir/ritonavir/ombitasvir + dasabuvir and ledipasvir/sofosbuvir is similar in patients who failed interferon-based treatment with first generation protease inhibitors

Author

Magdalena Tudrujek, Jerzy Jaroszewicz, Jolanta Białkowska-Warzecha, Iwona Orłowska, Tronina Olga, Rafał Krygier, Agnieszka Czauż-Andrzejuk, Simon Krzysztof, Krzysztof Tomasiewicz, Włodzimierz Mazur, P. Arkadiusz, Hanna Berak, Dorota Zarębska-Michaluk, Małgorzata Pawłowska, Teresa Belica-Wdowik, Jolanta Citko, Andrzej Gietka, Marta Wawrzynowicz-Syczewska, Waldemar Halota, Anna Piekarska, H. Andrzej, Łukasz Socha, Deron Zbigniew, Łukasz Laurans, A. Staniaszek, Dorota Dybowska, Robert Flisiak, Beata Lorenc, Aleksander Garlicki, Marek Sitko, Barbara Baka-Ćwierz, Beata Dobracka, and Ewa Janczewska

Subjects
Dasabuvir, Protease, Hepatology, business.industry, medicine.medical_treatment, Virology, Ombitasvir, First generation, chemistry.chemical_compound, chemistry, Paritaprevir, Interferon, Medicine, In patient, Ritonavir, business, medicine.drug
Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results